Suchergebnisse - "Takayama, Shin"

PubPharm (285)

1

Risk of Major Congenital Malformations Associated with the Use of Japanese Traditional (Kampo) Medicine Containing Ephedra During the First Trimester of Pregnancy

enthalten in: Drugs - real world outcomes | 2024

von Noda, A. | Obara, T. | Matsuzaki, F. | +16

2

Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer

enthalten in: Virchows Archiv : an international journal of pathology | 2023

von Miyakoshi, J. | Yazaki, S. | Shimoi, T. | +16

3

Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast cancer

enthalten in: Breast cancer (Tokyo, Japan) | 2023

von Murata, T. | Yoshida, M. | Shiino, S. | +11

4

Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer

enthalten in: Scientific reports | 2023

von Shikata, S. | Murata, T. | Yoshida, M. | +11

5

Contribution of traditional Japanese Kampo medicines, kakkonto with shosaikotokakikyosekko, in treating patients with mild-to-moderate coronavirus disease 2019 : Further analysis of a multicenter, randomized controlled trial

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2023

von Takayama, S. | Namiki, T. | Arita, R. | +16

6

Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy (PO-RAFAELO) Study under the Patient-proposed Health Services

enthalten in: JMA journal | 2023

von Takayama, S. | Kinoshita, T. | Shiino, S. | +12

7

Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast cancer

enthalten in: Breast cancer | 2023

von Murata, T. | Yoshida, M. | Shiino, S. | +11

8

Predictors for the Development of Hypoxia or Prolonged Acute Symptoms among Non-Hospitalized Mild-to-Moderate Patients with Coronavirus Disease 2019

enthalten in: The Tohoku journal of experimental medicine | 2023

von Tadano, Y. | Akaishi, T. | Suzuki, S. | +11

9

Correction : Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial

enthalten in: Breast cancer (Tokyo, Japan) | 2023

von Yamauchi, H. | Toi, M. | Takayama, S. | +7

ErratumFor: Breast Cancer. 2023 Jul;30(4):596-605. - PMID 37005966

10

Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial

enthalten in: Breast cancer (Tokyo, Japan) | 2023

von Yamauchi, H. | Toi, M. | Takayama, S. | +7

CommentIn: Breast Cancer. 2023 Nov;30(6):1107. - PMID 37166624

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[29]